Related references
Note: Only part of the references are listed.A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania
George M. Bwire et al.
SCIENTIFIC REPORTS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Pathophysiology of COVID-19: Why Children Fare Better than Adults?
Nitin Dhochak et al.
INDIAN JOURNAL OF PEDIATRICS (2020)
COVID-19 and malaria: A symptom screening challenge for malaria endemic countries
Pascalina Chanda-Kapata et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
Hao Cheng et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Rami Sommerstein et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
Christian Funck-Brentano et al.
LANCET (2020)
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
Nicola Principi et al.
LANCET INFECTIOUS DISEASES (2020)
The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
Joris R. Delanghe et al.
CLINICA CHIMICA ACTA (2020)
Tracking spending on malaria by source in 106 countries, 2000-16: an economic modelling study
Annie Haakenstad et al.
LANCET INFECTIOUS DISEASES (2019)
Patterns of inflammatory responses and parasite tolerance vary with malaria transmission intensity
Temitope W. Ademolue et al.
MALARIA JOURNAL (2017)
The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia
Sydney Mwanza et al.
MALARIA JOURNAL (2016)
Epigenetic impact of infection on carcinogenesis: mechanisms and applications
Naoko Hattori et al.
GENOME MEDICINE (2016)
Malaria and hypertension. Another co-evolutionary adaptation?
Samuel C. Wassmer
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
Impairment of the Plasmodium falciparum Erythrocytic Cycle Induced by Angiotensin Peptides
Victor Barbosa Saraiva et al.
PLOS ONE (2011)
Gene polymorphisms in angiotensin I converting enzyme (ACE I/D) and angiotensin II converting enzyme (ACE2 C → T) protect against cerebral malaria in Indian adults
Gunanidhi Dhangadamajhi et al.
INFECTION GENETICS AND EVOLUTION (2010)
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria
Stephane Picot et al.
MALARIA JOURNAL (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The geographic distribution of the ACE II genotype: a novel finding
Y. B. Saab et al.
GENETICS RESEARCH (2007)
Share Paper
